Xu Zhang1, Wei Zhang, Shwu-Fan Ma, Ankit A Desai, Santosh Saraf, Galina Miasniakova, Adelina Sergueeva, Tatiana Ammosova, Min Xu, Sergei Nekhai, Taimur Abbasi, Nancy G Casanova, Martin H Steinberg, Clinton T Baldwin, Paola Sebastiani, Josef T Prchal, Rick Kittles, Joe G N Garcia, Roberto F Machado, Victor R Gordeuk. 1. Comprehensive Sickle Cell Center, Section of Hematology/Oncology (X.Z., S.S., V.R.G.), Section of Cardiology (A.A.D.), and Section of Pulmonary, Critical Care, and Sleep Medicine (J.G.N.G., R.F.M.), Department of Medicine, Institute of Human Genetics (W.Z., R.K.), Department of Pediatrics (W.Z.), and Institute for Personalized Respiratory Medicine (A.A.D., T.A., N.G.C., J.G.N.G., R.F.M.), University of Illinois at Chicago, Chicago, IL; Section of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, IL (S-F.M.); Chuvash Republic Clinical Hospital 2, Cheboksary, Russia (G.M.); Cheboksary Children's Hospital, Cheboksary, Russia (A.S.); Center for Sickle Cell Disease, Howard University, Washington, DC (T.A., M.X., S.N.); Department of Medicine, Boston University School of Medicine, Boston, MA (M.H.S., C.T.B.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (P.S.); Hematology Division, University of Utah, Salt Lake City, UT (J.T.P.).
Abstract
BACKGROUND: We postulated that the hypoxic response in sickle cell disease (SCD) contributes to altered gene expression and pulmonary hypertension, a complication associated with early mortality. METHODS AND RESULTS: To identify genes regulated by the hypoxic response and not other effects of chronic anemia, we compared expression variation in peripheral blood mononuclear cells from 13 subjects with SCD with hemoglobin SS genotype and 15 subjects with Chuvash polycythemia (VHL(R200W) homozygotes with constitutive upregulation of hypoxia-inducible factors in the absence of anemia or hypoxia). At a 5% false discovery rate, 1040 genes exhibited >1.15-fold change in both conditions; 297 were upregulated and 743 downregulated including MAPK8 encoding a mitogen-activated protein kinase important for apoptosis, T-cell differentiation, and inflammatory responses. Association mapping with a focus on local regulatory polymorphisms in 61 patients with SCD identified expression quantitative trait loci for 103 of these hypoxia response genes. In a University of Illinois SCD cohort, the A allele of a MAPK8 expression quantitative trait locus, rs10857560, was associated with precapillary pulmonary hypertension defined as mean pulmonary artery pressure ≥25 mm Hg and pulmonary capillary wedge pressure ≤15 mm Hg at right heart catheterization (allele frequency, 0.66; odds ratio, 13.8; n=238). This association was confirmed in an independent Walk-Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy cohort (allele frequency, 0.65; odds ratio, 11.3; n=519). The homozygous AA genotype of rs10857560 was associated with decreased MAPK8 expression and present in all 14 of the identified precapillary pulmonary hypertension cases among the combined 757 patients. CONCLUSIONS: Our study demonstrates a prominent hypoxic transcription component in SCD and a MAPK8 expression quantitative trait locus associated with precapillary pulmonary hypertension.
BACKGROUND: We postulated that the hypoxic response in sickle cell disease (SCD) contributes to altered gene expression and pulmonary hypertension, a complication associated with early mortality. METHODS AND RESULTS: To identify genes regulated by the hypoxic response and not other effects of chronic anemia, we compared expression variation in peripheral blood mononuclear cells from 13 subjects with SCD with hemoglobin SS genotype and 15 subjects with Chuvash polycythemia (VHL(R200W) homozygotes with constitutive upregulation of hypoxia-inducible factors in the absence of anemia or hypoxia). At a 5% false discovery rate, 1040 genes exhibited >1.15-fold change in both conditions; 297 were upregulated and 743 downregulated including MAPK8 encoding a mitogen-activated protein kinase important for apoptosis, T-cell differentiation, and inflammatory responses. Association mapping with a focus on local regulatory polymorphisms in 61 patients with SCD identified expression quantitative trait loci for 103 of these hypoxia response genes. In a University of Illinois SCD cohort, the A allele of a MAPK8 expression quantitative trait locus, rs10857560, was associated with precapillary pulmonary hypertension defined as mean pulmonary artery pressure ≥25 mm Hg and pulmonary capillary wedge pressure ≤15 mm Hg at right heart catheterization (allele frequency, 0.66; odds ratio, 13.8; n=238). This association was confirmed in an independent Walk-Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy cohort (allele frequency, 0.65; odds ratio, 11.3; n=519). The homozygous AA genotype of rs10857560 was associated with decreased MAPK8 expression and present in all 14 of the identified precapillary pulmonary hypertension cases among the combined 757 patients. CONCLUSIONS: Our study demonstrates a prominent hypoxic transcription component in SCD and a MAPK8 expression quantitative trait locus associated with precapillary pulmonary hypertension.
Entities:
Keywords:
anemia, sickle cell; anoxia; gene expression; genetic association studies; hypertension, pulmonary; mitogen-activated protein kinase 8; quantitative trait loci
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal Journal: Nat Genet Date: 2002-11-04 Impact factor: 38.330
Authors: Vandana Sachdev; Gregory J Kato; J Simon R Gibbs; Robyn J Barst; Roberto F Machado; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico M Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Hwaida Hannoush; Jonathan C Goldsmith; Mark T Gladwin; Victor R Gordeuk Journal: Circulation Date: 2011-09-06 Impact factor: 29.690
Authors: Ankit A Desai; Tong Zhou; Homaa Ahmad; Wei Zhang; Wenbo Mu; Sharon Trevino; Michael S Wade; Nalini Raghavachari; Gregory J Kato; Marlene H Peters-Lawrence; Tejas Thiruvoipati; Kristin Turner; Nicole Artz; Yong Huang; Amit R Patel; Jason X-J Yuan; Victor R Gordeuk; Roberto M Lang; Joe G N Garcia; Roberto F Machado Journal: Am J Respir Crit Care Med Date: 2012-06-07 Impact factor: 21.405
Authors: Xiao Mei Wang; Yingze Zhang; Hong Pyo Kim; Zhihong Zhou; Carol A Feghali-Bostwick; Fang Liu; Emeka Ifedigbo; Xiaohui Xu; Tim D Oury; Naftali Kaminski; Augustine M K Choi Journal: J Exp Med Date: 2006-12-18 Impact factor: 14.307
Authors: Jin Han; Xu Zhang; Jennifer Oderinde; Santosh L Saraf; Michel Gowhari; Joharah Hassan; Shivi Jain; Victor R Gordeuk; Robert E Molokie Journal: Haematologica Date: 2017-05-04 Impact factor: 9.941
Authors: Andrew Srisuwananukorn; Rasha Raslan; Xu Zhang; Binal N Shah; Jin Han; Michel Gowhari; Robert E Molokie; Victor R Gordeuk; Santosh L Saraf Journal: Blood Adv Date: 2020-05-12
Authors: Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk Journal: Hum Genet Date: 2015-05-30 Impact factor: 4.132
Authors: Ankit A Desai; Zhengdeng Lei; Neil Bahroos; Mark Maienschein-Cline; Santosh L Saraf; Xu Zhang; Binal N Shah; Seyed M Nouraie; Taimur Abbasi; Amit R Patel; Roberto M Lang; Yves Lussier; Joe G N Garcia; Victor R Gordeuk; Roberto F Machado Journal: Blood Date: 2017-04-03 Impact factor: 22.113
Authors: Xu Zhang; Jihyun Song; Binal N Shah; Sergei Nekhai; Galina Miasnikova; Adelina Sergueeva; Josef T Prchal; Victor R Gordeuk Journal: Br J Haematol Date: 2020-05-12 Impact factor: 6.998